GEP20125531B - Reconstituted surfactants having improved properties - Google Patents

Reconstituted surfactants having improved properties

Info

Publication number
GEP20125531B
GEP20125531B GEAP200711224A GEAP2007011224A GEP20125531B GE P20125531 B GEP20125531 B GE P20125531B GE AP200711224 A GEAP200711224 A GE AP200711224A GE AP2007011224 A GEAP2007011224 A GE AP2007011224A GE P20125531 B GEP20125531 B GE P20125531B
Authority
GE
Georgia
Prior art keywords
surfactant
improved properties
reconstituted surfactants
reconstituted
native
Prior art date
Application number
GEAP200711224A
Other languages
English (en)
Inventor
Farmaceutici S P A Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20125531(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of GEP20125531B publication Critical patent/GEP20125531B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
GEAP200711224A 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties GEP20125531B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13

Publications (1)

Publication Number Publication Date
GEP20125531B true GEP20125531B (en) 2012-05-25

Family

ID=39079026

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP200711224A GEP20125531B (en) 2006-10-13 2007-09-28 Reconstituted surfactants having improved properties

Country Status (35)

Country Link
US (2) US8183210B2 (enExample)
EP (1) EP2078038B1 (enExample)
JP (2) JP5405307B2 (enExample)
KR (1) KR101328851B1 (enExample)
CN (2) CN103169947B (enExample)
AR (2) AR063263A1 (enExample)
AU (1) AU2007306075B2 (enExample)
BR (1) BRPI0715317B1 (enExample)
CA (1) CA2666344C (enExample)
CL (1) CL2007002931A1 (enExample)
CO (1) CO6400235A2 (enExample)
CY (1) CY1114716T1 (enExample)
DK (1) DK2078038T3 (enExample)
EA (1) EA015802B1 (enExample)
ES (1) ES2438727T3 (enExample)
GE (1) GEP20125531B (enExample)
HR (1) HRP20140052T1 (enExample)
IL (1) IL198075A (enExample)
JO (1) JO2963B1 (enExample)
MA (1) MA31062B1 (enExample)
ME (2) ME02326B (enExample)
MX (1) MX343064B (enExample)
MY (1) MY148127A (enExample)
NO (1) NO342038B1 (enExample)
NZ (1) NZ576189A (enExample)
PE (1) PE20081184A1 (enExample)
PL (1) PL2078038T3 (enExample)
PT (1) PT2078038E (enExample)
RS (1) RS53172B (enExample)
SI (1) SI2078038T1 (enExample)
TN (1) TN2009000099A1 (enExample)
TW (1) TWI388333B (enExample)
UA (1) UA94477C2 (enExample)
WO (1) WO2008044109A1 (enExample)
ZA (1) ZA200902481B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008011559A2 (en) 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
US9815869B2 (en) 2012-02-09 2017-11-14 University Of Rochester SP-B and SP-C peptides, synthetic lung surfactants, and use thereof
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
BR112015009486B1 (pt) 2012-11-21 2022-06-14 Chiesi Farmaceutici S.P.A Surfactante reconstituído, formulação farmacêutica, kit e uso de surfactante reconstituído
EP3393489B1 (en) * 2015-12-17 2021-09-01 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Synthetic lung surfactant with enhanced stability and effectiveness
CA3016810C (en) 2016-03-07 2024-04-02 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for administering ppar.gamma. agonists, surfactant peptides and phospholipids
CN109562139A (zh) 2016-08-24 2019-04-02 奇斯药制品公司 包含重构肺表面活性物质组合物的稳定药物制剂
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
EP4228691A4 (en) * 2020-10-16 2025-01-01 Biosuperior Technology, Inc. PULMONARY TREATMENT COMPOSITIONS
WO2025024609A1 (en) * 2023-07-25 2025-01-30 Biosuperior Technology, Inc. Polypeptides for lung surfactant compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0706374B1 (en) * 1993-06-30 1997-12-10 Genentech, Inc. Method for preparing liposomes
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
WO2008011559A2 (en) * 2006-07-20 2008-01-24 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
WO2008044109A1 (en) 2008-04-17
HK1134497A1 (en) 2010-04-30
PT2078038E (pt) 2013-12-12
JO2963B1 (en) 2016-03-15
EA200900373A1 (ru) 2009-10-30
US20130079275A1 (en) 2013-03-28
MA31062B1 (fr) 2010-01-04
ES2438727T3 (es) 2014-01-20
TW200824705A (en) 2008-06-16
ME02326B (me) 2016-06-20
US8183210B2 (en) 2012-05-22
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
CY1114716T1 (el) 2016-10-05
CA2666344A1 (en) 2008-04-17
IL198075A0 (en) 2011-08-01
CN103169947A (zh) 2013-06-26
TN2009000099A1 (en) 2010-08-19
NZ576189A (en) 2011-09-30
JP5405307B2 (ja) 2014-02-05
CN101522711A (zh) 2009-09-02
AU2007306075A1 (en) 2008-04-17
AR063263A1 (es) 2009-01-14
PL2078038T3 (pl) 2014-05-30
KR20090083892A (ko) 2009-08-04
HRP20140052T1 (hr) 2014-02-28
MEP12109A (en) 2011-12-20
US9238058B2 (en) 2016-01-19
JP2013241449A (ja) 2013-12-05
AR113422A2 (es) 2020-04-29
EP2078038A1 (en) 2009-07-15
BRPI0715317A2 (pt) 2013-07-09
ZA200902481B (en) 2010-07-28
CA2666344C (en) 2017-04-18
CN101522711B (zh) 2013-11-13
EA015802B1 (ru) 2011-12-30
MY148127A (en) 2013-02-28
EP2078038B1 (en) 2013-11-20
JP2010505937A (ja) 2010-02-25
AU2007306075B2 (en) 2012-08-09
HK1185274A1 (en) 2014-02-14
TWI388333B (zh) 2013-03-11
SI2078038T1 (sl) 2014-02-28
RS53172B (sr) 2014-06-30
BRPI0715317B1 (pt) 2021-10-05
MX2009003638A (es) 2009-04-22
CL2007002931A1 (es) 2008-03-24
MX343064B (es) 2016-10-24
KR101328851B1 (ko) 2013-11-14
PE20081184A1 (es) 2008-09-26
NO20091441L (no) 2009-06-23
UA94477C2 (ru) 2011-05-10
US20100004173A1 (en) 2010-01-07
DK2078038T3 (da) 2013-12-02
IL198075A (en) 2016-04-21
NO342038B1 (no) 2018-03-19

Similar Documents

Publication Publication Date Title
GEP20125531B (en) Reconstituted surfactants having improved properties
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
MY159464A (en) Reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
UA95235C2 (en) Glucagon-like-peptide-2 (glp-2) analogues
MY161617A (en) Removal of serine proteases by treatment with finely divided silicon dioxide
MX2021008131A (es) Metodos y composiciones para el tratamiento de la enfermedad de fabry.
WO2009010968A3 (en) Disease treatment via antimicrobial peptides or their inhibitors
EA201000161A1 (ru) Синтетические поверхностно-активные пептиды легких
NO20080552L (no) GLP-1 farmasoytiske sammensetninger
SE0401631L (sv) Ny sammansättning
WO2005074626A3 (en) Compositions, methods and uses for a novel family of peptides
AU2003251728A1 (en) Placental growth factor as a target for the treatment of osteoporosis
MX2009006942A (es) Composiciones farmaceuticas de glp-1.
DE60118898D1 (de) Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
CL2019003179A1 (es) Eliminación de serina proteasas por tratamiento con dióxido de silicio finamente dividido. (divisional solicitud 201203291)
WO2024173352A3 (en) Methods of treating cancer with a sirp1a-based chimeric protein
UA96003C2 (en) PHARMACEUTICAL COMPOSITION [Aib8,35]hGLP-1(7-36)NH2
DOP2009000265A (es) Polipeptidos, dominios variables de anticuerpos y antagonistas